Kunming Longjin Pharmaceutical Co., Ltd. Profile Avatar - Palmy Investing

Kunming Longjin Pharmaceutical Co., Ltd.

Kunmig Longjin Pharmaceutical Co., Ltd. develops, produces, and sells natural botanicals and chemical freeze-dried powder injections in China. The company offers Chinese, biochemical, chemical, cardio-cerebral vascular, and digestive system medicines; im…

Drug Manufacturers - Specialty & Generic
CN, Kunming [HQ]

Ratios

13 Records · Starting from 2011
Margins, Growth Rates In %
Ratio 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
76.89 72.17 73.41 69.17 65.28 79.86 88.83 90.13 82.47 79.79 31.07 79.20 60.89
Profit Margin
46.89 55.01 41.97 33.92 34.06 40.71 11.55 4.13 -8.70 3.05 -1.06 -59.80 -81.90
Operating Margin
54.33 62.68 48.12 39.15 35.79 43.44 13.73 4.97 12.75 3.40 0.99 -27.81 -94.59
EPS Growth
- - 43.48 -24.24 -16.00 -23.81 43.75 -61.83 -60.59 -272.83 132.44 -195.88 -867.74 - -
Return on Assets (ROA)
24.24 27.22 16.96 14.59 8.84 11.98 4.48 1.76 -2.97 0.92 -0.90 -9.84 -11.23
Return on Equity (ROE)
37.30 44.15 24.85 22.26 10.31 13.58 5.45 2.14 -3.83 1.22 -1.17 -12.61 -13.86
Return on Invested Capital (ROIC)
33.31 42.64 23.83 19.50 9.20 13.09 5.59 2.28 6.03 1.44 1.45 -6.26 -16.37
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
6.96 - - - - 6.99 0.05 -1.12 -0.18 -0.32 -0.29 0.18 0.16 0.16 0.16
Debt/Equity
10.71 - - - - 10.66 0.06 -1.26 -0.22 -0.39 -0.37 0.23 0.21 0.20 0.19
Debt/EBITDA
-50.99 -78.79 -96.77 -62.86 -207.01 -44.22 -115.27 -1,439.73 -318.83 -325.54 -266.67 2,274.68 4,258.86
Debt/Capitalization
9.67 - - - - 9.63 0.06 -1.28 -0.22 -0.39 -0.37 0.23 0.21 0.20 0.19
Interest Debt per Share CNY
0.07 - - - - 0.11 - - -0.02 - - 0.02 -0.01 - - - - 0.04 - -
Debt Growth
- - -100.00 - - - - -98.82 -25.00 -100.00 - - - - - - -10.60 -12.41 -14.83
Liquidity
Current Ratio
119.67 95.02 102.89 109.13 594.69 730.91 427.82 475.25 455.56 518.14 461.01 537.36 765.98
Quick Ratio
111.50 86.93 92.77 96.19 568.66 693.45 401.12 447.92 421.63 463.62 431.99 505.67 708.84
Cash Ratio
70.59 73.72 73.10 73.89 284.45 90.06 63.36 386.47 185.68 123.63 89.98 217.98 420.31
Operating Cash Flow Ratio
- - - - - - - - 100 100 - - - - - - - - - - - - - -
Turnover
Inventory Turnover
466.05 484.97 394.92 356.84 345.36 195.36 113.86 121.93 135.13 93.92 1,471.66 92.05 118.26
Receivables Turnover
475.02 1,079.70 786.74 674.56 652.03 1,167.86 580.43 690.69 739.70 529.68 1,239.54 349.69 691.93
Payables Turnover
230.23 298.55 107.74 225.82 723.99 774.41 501.45 221.24 345.00 336.11 4,095.15 253.10 364.55
Asset Turnover
51.70 49.49 40.41 43.02 25.96 29.44 38.77 42.66 34.12 30.18 84.92 16.46 13.71
Coverage
Interest Coverage
6,896.38 18,756.28 42,063.26 5,234.78 15,098.96 - - 4,585.83 162.25 105,801.27 26,298.80 1,479.03 -259.44 - -
Asset Coverage
900 - - - - 1,000 171,800 252,000 - - - - - - 47,100 50,500 53,200 53,300
Cash Flow Coverage (CFGR)
379.49 - - - - 230.47 19,790.59 -1,230.76 -4,097.28 -1,254.28 -174.08 -459.45 -1,122.72 -1,250.57 -3,991.42
EBITDA Coverage
7,300 19,800 43,900 7,000 22,300 - - 6,700 200 184,700 114,400 8,000 - - - -
Dividend Coverage
-5,900 -16,400 -100 - - -100 -400 - - -100 - - - - 1,800 - - - -
Time Interest Earned (TIE)
200 300 200 200 200 100 100 100 100 100 - - - - - -
Market Prospects
Dividend Yield
0.09 0.04 4.38 5.94 0.69 0.31 1.58 0.54 - - - - 0.01 - - - -
Earnings Yield
5.08 7.31 5.48 4.64 0.85 1.39 0.92 0.62 -0.46 0.23 -0.12 -1.65 -1.77
Price/Earnings (P/E)
19.6720 13.6761 18.2567 21.5566 118.2164 72.0804 108.4168 161.7003 -215.3336 432.8195 -865.9398 -60.6236 -56.4653
Price/Book (P/B)
733.83 603.84 453.74 479.89 1,218.78 978.71 590.50 346.43 825.71 527.66 1,010.73 764.55 782.54
Price/Sales (P/S)
922.44 752.39 766.15 731.27 4,026.89 2,934.20 1,252.07 667.53 1,872.35 1,321.20 919.56 3,625.05 4,624.35
Price/Cash Flow (P/CF)
1,805.51 1,503.19 1,287.15 1,953.19 10,409.48 6,294.97 6,565.71 7,075.35 127,481.56 -49,523.76 -43,636.64 -30,862.95 -10,202.89
End of 002750.SZ's Analysis
CIK: - CUSIP: - ISIN: CNE1000021X8 LEI: - UEI: -
Secondary Listings
002750.SZ has no secondary listings inside our databases.